FDA NDC Directory · JSON-LD · Markdown

NovoLog Mix 70/30

NDC 0169-2201 · HUMAN PRESCRIPTION DRUG · INJECTION, SUSPENSION

Generic nameinsulin aspart
Labeler / ManufacturerNovo Nordisk
Marketing categoryBiologic License Application · App BLA021172
Dosage form / routeINJECTION, SUSPENSION · SUBCUTANEOUS
Active ingredientsINSULIN ASPART (100 [iU]/mL)
Marketing started20020911
Package count1

External sources

Source: openFDA. Public-domain (CC0).